Prospects for Bayer's oral Factor XIa inhibitor asundexian were looking speculative when it failed a phase 3 trial in atrial fibrillation (AF), but new data in secondary stroke prevention could get ...
Northwestern Medicine Palos Hospital has received Advanced Primary Stroke Center Certification by The Joint Commission, the nation’s oldest and largest standards-setting and accrediting body in health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback